These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33444590)

  • 1. Cardiac Amyloidosis for the Primary Care Provider: A Practical Review to Promote Earlier Recognition of Disease.
    Zhang KW; Vallabhaneni S; Alvarez-Cardona JA; Krone RJ; Mitchell JD; Lenihan DJ
    Am J Med; 2021 May; 134(5):587-595. PubMed ID: 33444590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early cardiac involvement in senile systemic amyloidosis: a case report.
    Yamano M; Azuma A; Yazaki M; Ikeda S; Sawada T; Matsubara H
    Amyloid; 2008 Mar; 15(1):54-9. PubMed ID: 18266122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stiff heart syndrome.
    Bhupathi SS; Chalasani S; Rokey R
    Clin Med Res; 2011 Jun; 9(2):92-9. PubMed ID: 20852084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease.
    Thomas VE; Smith J; Benson MD; Dasgupta NR
    Neurodegener Dis Manag; 2019 Dec; 9(6):289-299. PubMed ID: 31686587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correct Diagnosis of Wild-Type Transthyretin-Related Amyloidosis Followed by the Introduction of a Novel Therapy in a Patient With Cardiac Wall Thickening of Unknown Cause.
    Sawada N; Nakayama A; Takahashi M; Tanaka M; Morita H; Akazawa H; Komuro I
    Int Heart J; 2017 Feb; 58(1):147-150. PubMed ID: 28111409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
    Di Giovanni B; Gustafson D; Delgado DH
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.
    Puig-Carrion GD; Reyentovich A; Katz SD
    Clin Auton Res; 2019 Sep; 29(Suppl 1):45-53. PubMed ID: 31452023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Cardiac Amyloidosis: Do's and Don'ts.
    Alexander KM; Witteles RM
    Can J Cardiol; 2020 Mar; 36(3):444-446. PubMed ID: 32033795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Suspected cardiac amyloidosis - diagnostic steps for evaluation].
    Feldmann K; Hamm CW; Aßmus B
    Dtsch Med Wochenschr; 2020 Aug; 145(16):1162-1168. PubMed ID: 32791553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Grogan M; Dispenzieri A; Gertz MA
    Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac amyloidosis: An update on diagnosis and treatment.
    Donnelly JP; Hanna M
    Cleve Clin J Med; 2017 Dec; 84(12 Suppl 3):12-26. PubMed ID: 29257735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings.
    Vergaro G; Aimo A; Barison A; Genovesi D; Buda G; Passino C; Emdin M
    Eur J Prev Cardiol; 2020 Nov; 27(17):1806-1815. PubMed ID: 31581822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac amyloidosis: a case report and therapeutic implications.
    Kotha AR; Weiss MB
    Heart Dis; 2002; 4(2):86-90. PubMed ID: 11975839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving strategies for the diagnosis of cardiac amyloidosis.
    Kourelis TV; Gertz MA
    Expert Rev Cardiovasc Ther; 2015; 13(8):945-61. PubMed ID: 26174181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac amyloidosis presumptively diagnosed as cardiac syndrome X.
    Yagishita A; Tanimoto S; Tanabe K; Isogawa A; Taniguchi M; Shiba T; Hara K
    Circ J; 2009 Jul; 73(7):1349-51. PubMed ID: 19122303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fundamentals of Light Chain Cardiac Amyloidosis: A Focused Review.
    Latif A; Lateef N; Razzaq F; Kapoor V; Ahsan MJ; Ashfaq M; Iftikhar A; Anwer F; Holmberg M; William P
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(4):274-283. PubMed ID: 33256586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
    Fine NM; Davis MK; Anderson K; Delgado DH; Giraldeau G; Kitchlu A; Massie R; Narayan J; Swiggum E; Venner CP; Ducharme A; Galant NJ; Hahn C; Howlett JG; Mielniczuk L; Parent MC; Reece D; Royal V; Toma M; Virani SA; Zieroth S
    Can J Cardiol; 2020 Mar; 36(3):322-334. PubMed ID: 32145862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.